Endocrine News and Research

RSS

Everolimus plus tamoxifen delays disease progression in HR+/HER2- metastatic breast cancer

A new study shows that the addition of everolimus (Afinitor® tablets) to the hormonal therapy tamoxifen in patients with hormone-receptor positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer who have been previously treated with an aromatase inhibitor (AI) delays disease progression compared to tamoxifen alone. These results were presented today at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium in San Antonio, Texas.

10 Dec 2010

Results of Adjuvant Treatment with Zoledronic Acid in Stage II/III Breast Cancer to be presented at symposium

The long-awaited results of the Adjuvant Treatment with Zoledronic Acid in Stage II/III Breast Cancer, the AZURE trial, will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held here Dec. 8-12.

10 Dec 2010

Oral contraceptives account for less than 1% of estrogen in drinking water

Contrary to popular belief, birth control pills account for less than 1 percent of the estrogens found in the nation's drinking water supplies, scientists have concluded in an analysis of studies published on the topic.

9 Dec 2010

Study demonstrates new test for early diagnosis of Turner syndrome

A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) has demonstrated a novel and accurate test for early diagnosis of Turner syndrome. Turner syndrome affects one in 1,500 to 2,000 female live births and early diagnosis allows for the timely management of short stature and co-morbid conditions including cardiac and renal problems.

9 Dec 2010

Bisphenol A tainted money and receipts

Bisphenol A (BPA) has been found in many household items and other common objects and is known to be an endocrine disruptor linked to infertility, genital abnormalities, cancer and more. Now it has been detected on ‘cash’. Since BPA is used to make plastic, manufacturers use about 8 billion pounds of BPA that is moulded, cooked or poured into toys, baby products and other merchandise each year. On these products BPA is chemically bonded but it is simply applied in a powdery film to paper, making it easy to rub off with a touch.

8 Dec 2010

Low and high vitamin D levels may increase frailty in older women

A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that lower and higher vitamin D levels were associated with an increased likelihood of frailty in older women. Women with vitamin D levels between 20.0 and 29.9 ng/ml were at the lowest risk of frailty.

8 Dec 2010

TOS, OAC call on FDA to address urgent need for obesity treatments

The Obesity Society (TOS) and the Obesity Action Coalition (OAC) today called on the Food and Drug Administration (FDA) to consider the urgent need for more tools to address the obesity epidemic facing more than 93 million Americans as they convene an advisory panel to review a new treatment for obesity.

8 Dec 2010

FDA advisory committee's approval of Contrave for obesity encourages OAC, TOS, ASMBS

The Obesity Action Coalition, The Obesity Society and the American Society for Metabolic and Bariatric Surgery found encouragement in the outcome of today's advisory committee hearing, favoring approval for the first new obesity treatment in more than 10 years.

8 Dec 2010

Expansion of newborn screening throws some families on a journey of great uncertainty

Mandatory genetic screening of newborns for rare diseases is creating unexpected upheaval for families whose infants test positive for risk factors but show no immediate signs of the diseases, a new UCLA study warns.

7 Dec 2010

New, HIV-like retroviruses linked to CFS, prostate cancer detected in healthy blood donors

In an unprecedented move, chronic fatigue syndrome patients published a half-page ad in The Washington Post today. The ad brings attention to new, HIV-like retroviruses, including XMRV, which have been linked to CFS and aggressive prostate cancer, and have been detected in healthy blood donors.

6 Dec 2010

Event reporting prevents medication errors in primary care: Study

The most frequent contributors to medication errors and adverse drug events in busy primary care practice offices are communication problems and lack of knowledge, according to a study of a prototype web-based medication error and adverse drug event reporting system.

4 Dec 2010

Spherix announces results of D-tagatose Phase 3 trial for Type 2 diabetes

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced results from its first Phase 3 trial post hoc analysis in which the higher body mass index (BMI) of the U.S. population relative to the Indian population was a likely key contributor to the more positive effects of D-tagatose in the lowering of HbA1c levels in the U.S. population. Initial results were announced on October 7.

2 Dec 2010

Exposure to BPA during perinatal development impairs reproductive capacity of female offspring

Exposure to a ubiquitous environmental chemical during pregnancy may impair reproductive capacity of female offspring, according to a study published online in advance of print on December 2 in Environmental Health Perspectives. Fertility decreased over time in female mice that had been exposed during fetal and neonatal (perinatal) development to doses of bisphenol-A (BPA) that were lower than or equal to human environmental exposure levels.

2 Dec 2010

Study reveals major findings of National Cancer Registry of Spain for Gastroenteropancreatic Neuroendocrine Tumours

The National Cancer Registry of Spain for Gastroenteropancreatic Neuroendocrine Tumours (RGETNE) is the first initiative of its type in southern Europe and focuses its efforts on profiling the incidence of gastroenteropancreatic tumours, improving diagnosis and treatment efficacy, and determining the clinical profile of patients across Spain.

1 Dec 2010

Sinai Hospital's endocrinologist helps people to manage diabetes

Nearly 27-million people live with diabetes and 57-million more are pre-diabetic. Not only can this disease be life threatening, but it can take a huge toll on families and on those who have it- if it's not treated properly.

30 Nov 2010

Overexposure to triclosan may negatively influence immune system: Study

Young people who are overexposed to antibacterial soaps containing triclosan may suffer more allergies, and exposure to higher levels of Bisphenol A among adults may negatively influence the immune system, a new University of Michigan School of Public Health study suggests.

29 Nov 2010

Study suggests less than 10% of UK adults with CAH receive specialist endocrine care

A new study suggests that less than 10% of the estimated 3,591 adults in the UK with the genetic condition congenital adrenal hyperplasia (CAH) receive specialist endocrine care, and that there is no standard treatment for these patients.

26 Nov 2010

Harvard researcher to receive 2010 Naomi Berrie Award from Columbia University Medical Center

Columbia University Medical Center will present the 2010 Naomi Berrie Award to a Harvard researcher who has made important advances in understanding the molecular basis for links between obesity, diabetes and heart disease. A promising young investigator at Columbia will also be recognized for her novel investigations regarding the basis for disordered lipid metabolism in diabetes.

20 Nov 2010

PAREXEL reaches milestone in early phase studies

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it reached a milestone of completing 200 early phase studies in patient populations during the past three years.

From Parexel 18 Nov 2010

New cellular pathway could help develop therapeutic treatments for obesity-related disorders

Cardiac researchers at the University of Cincinnati (UC) have found a new cellular pathway that could help in developing therapeutic treatments for obesity-related disorders, like diabetes and heart disease.

17 Nov 2010

Endocrine News and Research

Everolimus plus tamoxifen delays disease progression in HR+/HER2- metastatic breast cancer

Results of Adjuvant Treatment with Zoledronic Acid in Stage II/III Breast Cancer to be presented at symposium

Oral contraceptives account for less than 1% of estrogen in drinking water

Study demonstrates new test for early diagnosis of Turner syndrome

Bisphenol A tainted money and receipts

Low and high vitamin D levels may increase frailty in older women

TOS, OAC call on FDA to address urgent need for obesity treatments

FDA advisory committee's approval of Contrave for obesity encourages OAC, TOS, ASMBS

Expansion of newborn screening throws some families on a journey of great uncertainty

New, HIV-like retroviruses linked to CFS, prostate cancer detected in healthy blood donors

Event reporting prevents medication errors in primary care: Study

Spherix announces results of D-tagatose Phase 3 trial for Type 2 diabetes

Exposure to BPA during perinatal development impairs reproductive capacity of female offspring

Study reveals major findings of National Cancer Registry of Spain for Gastroenteropancreatic Neuroendocrine Tumours

Sinai Hospital's endocrinologist helps people to manage diabetes

Overexposure to triclosan may negatively influence immune system: Study

Study suggests less than 10% of UK adults with CAH receive specialist endocrine care

Harvard researcher to receive 2010 Naomi Berrie Award from Columbia University Medical Center

PAREXEL reaches milestone in early phase studies

New cellular pathway could help develop therapeutic treatments for obesity-related disorders

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News